Circulating eNAMPT and resistin as emerging biomarkers in sepsis

I. Karampela (Chaidari, Greece), E. Kandri (Athens, Greece), G. Christodoulatos (Athens, Greece), G. Skyllas (Chaidari, Greece), E. Chrysanthopoulou (Chaidari, Greece), G. Antonakos (Chaidari, Greece), E. Voyatzakis (Athens, Greece), A. Armaganidis (Chaidari, Greece), M. Dalamaga (Athens, Greece)

Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers
Session: Critically ill patients: prognostic factors and biomarkers
Session type: Thematic Poster
Number: 2305
Disease area: Respiratory critical care

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Karampela (Chaidari, Greece), E. Kandri (Athens, Greece), G. Christodoulatos (Athens, Greece), G. Skyllas (Chaidari, Greece), E. Chrysanthopoulou (Chaidari, Greece), G. Antonakos (Chaidari, Greece), E. Voyatzakis (Athens, Greece), A. Armaganidis (Chaidari, Greece), M. Dalamaga (Athens, Greece). Circulating eNAMPT and resistin as emerging biomarkers in sepsis. 2305

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: